Do you want to read an article? Please log in or register.
A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Fibrosis
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
Cochrane Database Syst Rev.
Smith S, Rowbotham NJ, Charbek E
doi: 10.1002/14651858.
Pulmonary Fibrosis
Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis
Chest.
Hong LT, Liou TG, Deka R, King JB, Stevens V, Young DC
doi: 10.1016/j.chest.2018.06.002.
COPD
Population exacerbation incidence contains predictive information of acute exacerbations in patients with chronic obstructive pulmonary disease in telecare
Int J Med Inform.
Kronborg T, Mark L, Cichosz SL, Secher PH, Hejlesen O
doi: 10.1016/j.ijmedinf.
RECOMMENDED
COPDEmphysemaPulmonary Fibrosis
Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Zantah M, Dotan Y, Dass C, Zhao H, Marchetti N, Criner GJ
doi: 10.1186/s12931-020-01432-x.
Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis
Thorax.
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F
doi: 10.1136/
RECOMMENDED
Pulmonary Fibrosis
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Frost F, Young GR, Wright L, Miah N, Smith DL, Winstanley C, Walshaw MJ, Fothergill JL, Nazareth D
doi: 10.1016/j.jcf.2020.12.012
RECOMMENDED
Pulmonary Fibrosis
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H, EXAFIP investigators and the OrphaLung network.
doi: 10.1016/S2213-2600(21)00354-4
RECOMMENDED
Pulmonary Fibrosis
Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Nicholson TT, Smith A, McKone EF, Gallagher CG
doi: 10.1016/j.jcf.2021.08.017
RECOMMENDED
Pulmonary Fibrosis
Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
McLeod C, Wood J, Schultz A, Norman R, Smith S, Blyth CC, Webb S, Smyth AR, Snelling TL
doi: 10.1016/j.jcf.2020.08.015